These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 23212374)

  • 21. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians.
    Biagi E; Nylund L; Candela M; Ostan R; Bucci L; Pini E; Nikkïla J; Monti D; Satokari R; Franceschi C; Brigidi P; De Vos W
    PLoS One; 2010 May; 5(5):e10667. PubMed ID: 20498852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the gut microbiota in age-related chronic inflammation.
    Rehman T
    Endocr Metab Immune Disord Drug Targets; 2012 Dec; 12(4):361-7. PubMed ID: 23017185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes.
    Serino M; Blasco-Baque V; Burcelin R
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S27-8. PubMed ID: 22955352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice.
    Wu M; Yang S; Wang S; Cao Y; Zhao R; Li X; Xing Y; Liu L
    Front Pharmacol; 2020; 11():223. PubMed ID: 32231564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of metabolism: a cross talk between gut microbiota and its human host.
    Burcelin R
    Physiology (Bethesda); 2012 Oct; 27(5):300-7. PubMed ID: 23026753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting gut microbiota in obesity: effects of prebiotics and probiotics.
    Delzenne NM; Neyrinck AM; Bäckhed F; Cani PD
    Nat Rev Endocrinol; 2011 Aug; 7(11):639-46. PubMed ID: 21826100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota: Dietary and social modulation of gut microbiota in the elderly.
    Kinross J; Nicholson JK
    Nat Rev Gastroenterol Hepatol; 2012 Oct; 9(10):563-4. PubMed ID: 22945446
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment.
    Kappel BA; De Angelis L; Heiser M; Ballanti M; Stoehr R; Goettsch C; Mavilio M; Artati A; Paoluzi OA; Adamski J; Mingrone G; Staels B; Burcelin R; Monteleone G; Menghini R; Marx N; Federici M
    Mol Metab; 2020 Jun; 36():100976. PubMed ID: 32251665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota and obesity.
    Krznarić Z; Vranešić Bender D; Kunović A; Kekez D; Stimac D
    Dig Dis; 2012; 30(2):196-200. PubMed ID: 22722438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of atherosclerosis susceptibility with gut microbial transplantation.
    Gregory JC; Buffa JA; Org E; Wang Z; Levison BS; Zhu W; Wagner MA; Bennett BJ; Li L; DiDonato JA; Lusis AJ; Hazen SL
    J Biol Chem; 2015 Feb; 290(9):5647-60. PubMed ID: 25550161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?
    Musso G; Gambino R; Cassader M
    Diabetes Care; 2010 Oct; 33(10):2277-84. PubMed ID: 20876708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.
    Cryan JF; Dinan TG
    Nat Rev Neurosci; 2012 Oct; 13(10):701-12. PubMed ID: 22968153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis.
    Kasahara K; Tanoue T; Yamashita T; Yodoi K; Matsumoto T; Emoto T; Mizoguchi T; Hayashi T; Kitano N; Sasaki N; Atarashi K; Honda K; Hirata KI
    J Lipid Res; 2017 Mar; 58(3):519-528. PubMed ID: 28130274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing.
    Louis S; Tappu RM; Damms-Machado A; Huson DH; Bischoff SC
    PLoS One; 2016; 11(2):e0149564. PubMed ID: 26919743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host-gut microbiota metabolic interactions.
    Nicholson JK; Holmes E; Kinross J; Burcelin R; Gibson G; Jia W; Pettersson S
    Science; 2012 Jun; 336(6086):1262-7. PubMed ID: 22674330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of gut microbiota in fetal methylmercury exposure: Insights from a pilot study.
    Rothenberg SE; Keiser S; Ajami NJ; Wong MC; Gesell J; Petrosino JF; Johs A
    Toxicol Lett; 2016 Feb; 242():60-67. PubMed ID: 26626101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota and the pathogenesis of insulin resistance.
    Delzenne NM; Cani PD
    Curr Diab Rep; 2011 Jun; 11(3):154-9. PubMed ID: 21431853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid metabolism by gut microbes and atherosclerosis.
    Loscalzo J
    Circ Res; 2011 Jul; 109(2):127-9. PubMed ID: 21737814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.